John Scott is director of the Division of Biostatistics in Center Biologics Evaluation and Research at the Food and Drug Administration (FDA), where he has also served as deputy director and as a statistical reviewer for blood products and cellular, tissue and gene therapies.
Prior to joining the FDA in 2008, he worked in psychiatric clinical trials at the UPMC Western Psychiatric Hospital. He has authored or co-authored numerous articles in areas including Bayesian and adaptive clinical trial design and analysis, drug and vaccine safety, data and text mining, and benefit-risk assessment.
Scott earned his PhD in biostatistics from the University of Pittsburgh, his AM in mathematics from Washington University in St. Louis, and his BA in liberal arts from Sarah Lawrence College. He is a Fellow of the American Statistical Association and is a past editor of Pharmaceutical Statistics.
11/30/2021